Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Activities of Daily Living and Associated Costs in the Most Widespread Neurodegenerative Diseases: A Systematic Review</p>
Petra Marešová, Jan Hruška, Blanka Klímová, et al.
Clinical Interventions in Aging (2020) Vol. Volume 15, pp. 1841-1862
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation
Hossein Ashrafian, Elaheh Hadi Zadeh, Rizwan Hasan Khan
International Journal of Biological Macromolecules (2020) Vol. 167, pp. 382-394
Closed Access | Times Cited: 266
Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age
Ashley Payne, Samuel N. Nahashon, Equar Taka, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 371-371
Open Access | Times Cited: 109
Evaluation of ChatGPT’s responses to information needs and information seeking of dementia patients
Hamid Reza Saeidnia, Marcin Kozak, Brady Lund, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
EEGConvNeXt: A Novel Convolutional Neural Network Model for Automated Detection of Alzheimer's Disease and Frontotemporal Dementia Using EEG Signals
Madhav R. Acharya, Ravinesh C. Deo, Prabal Datta Barua, et al.
Computer Methods and Programs in Biomedicine (2025) Vol. 262, pp. 108652-108652
Closed Access | Times Cited: 1
Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic Effects of Flavonols: Targeting Nrf2, NF-κB and p53 Pathways in Neurodegeneration
Maja Jazvinšćak Jembrek, Nada Oršolić, Lucija Mandić, et al.
Antioxidants (2021) Vol. 10, Iss. 10, pp. 1628-1628
Open Access | Times Cited: 51
Neuropsychiatric symptoms and their neural correlates in individuals with mild cognitive impairment
Natascia De Lucia, Giovanni Carbone, Benedetta Muzii, et al.
International Psychogeriatrics (2023) Vol. 35, Iss. 11, pp. 623-632
Open Access | Times Cited: 17
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer’s disease with dementia
Nikias Siafarikas, Dag Alnæs, Jennifer Monereo‐Sánchez, et al.
International Psychogeriatrics (2021) Vol. 33, Iss. 11, pp. 1217-1228
Closed Access | Times Cited: 29
Therapeutic Role of Repetitive Transcranial Magnetic Stimulation in Alzheimer’s and Parkinson’s Disease: Electroencephalography Microstate Correlates
Lütfü Hanoğlu, Eren Toplutaş, Mevhibe Sarıcaoğlu, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
The role of basket trials in drug development for neurodegenerative disorders
Jeffrey L. Cummings, A. Montes, Sana Kamboj, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents
Pasquale Linciano, Claudia Sorbi, Giacomo Rossino, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115163-115163
Open Access | Times Cited: 12
Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐finding studies in healthy participants and an open‐label study in participants with Huntington's disease
Aaron Koenig, Michael Lewis, Jeff Wald, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 4
Exploring Synergies in Brain-Machine Interfaces: Compression vs. Performance
Luis H. Cubillos, Madison Kelberman, Matthew J. Mender, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases?
Simone Carradori, Marialuigia Fantacuzzi, Alessandra Ammazzalorso, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7816-7816
Open Access | Times Cited: 17
Targeting mGluR group III for the treatment of neurodegenerative diseases
Nadia Rabeh, Baraa Hajjar, Jude O. Maraka, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115733-115733
Open Access | Times Cited: 10
Suicide and dementia: A systematic review and meta-analysis of prevalence and risk factors
Roopal Desai, Anastasia Tsipa, Caroline Fearn, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102445-102445
Open Access | Times Cited: 3
Current pharmacophore based approaches for the development of new anti-Alzheimer’s agents
Prachi Sharma, Sunil Sharma, Yogesh Yadav, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117926-117926
Closed Access | Times Cited: 3
A Decision-Tree Approach to Assist in Forecasting the Outcomes of the Neonatal Brain Injury
Bogdan Neamțu, Gabriela Vişa, Ionela Maniu, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 9, pp. 4807-4807
Open Access | Times Cited: 22
Non-coding RNAs in Alzheimer’s disease: perspectives from omics studies
Erming Wang, Mariana Lemos Duarte, Lauren E Rothman, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. R1, pp. R54-R61
Open Access | Times Cited: 14
Measuring Brain Activation Patterns from Raw Single-Channel EEG during Exergaming: A Pilot Study
Gianluca Amprimo, Irene Rechichi, Claudia Ferraris, et al.
Electronics (2023) Vol. 12, Iss. 3, pp. 623-623
Open Access | Times Cited: 9
Targeting the microbiota-mitochondria crosstalk in neurodegeneration with senotherapeutics
Jan Homolak
Advances in protein chemistry and structural biology (2023), pp. 339-383
Closed Access | Times Cited: 8
Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia
Julie J. McInvale, Peter Canoll, Gunnar Hargus
Brain Pathology (2024) Vol. 34, Iss. 4
Open Access | Times Cited: 2
Long-Term Impact of Deep Brain Stimulation in Parkinson’s Disease: Does It Affect Rehabilitation Outcomes?
Margherita Canesi, Lorenzo Lippi, Simone Rivaroli, et al.
Medicina (2024) Vol. 60, Iss. 6, pp. 927-927
Open Access | Times Cited: 2
Internet-facilitated interventions for informal caregivers of patients with neurodegenerative disorders: Systematic review and meta-analysis
Neil Boyt, Aileen K. Ho, Hannah Morris-Bankole, et al.
Digital Health (2022) Vol. 8, pp. 205520762211290-205520762211290
Open Access | Times Cited: 11
The effect of cognitive training on domains of attention in older adults with mild cognitive impairment and mild dementia: A meta-analysis of randomised controlled trials
Chien‐Mei Sung, Hsiu‐Ju Jen, Doresses Liu, et al.
Journal of Global Health (2023) Vol. 13
Open Access | Times Cited: 6
Patients’ Stem Cells Differentiation in a 3D Environment as a Promising Experimental Tool for the Study of Amyotrophic Lateral Sclerosis
Eveljn Scarian, Matteo Bordoni, Valentina Fantini, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5344-5344
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top